Statins and adhesion molecules: a review of a novel pleiotropic property of statins (original) (raw)

• Tvaroška I, Selvaraj C, Koča J. Selectins—the two Dr. Jekyll and Mr. Hyde faces of adhesion molecules—a review. Molecules. 2020;25(12):2835.
  Article PubMed PubMed Central Google Scholar
• Mosevoll KA, Johansen S, Wendelbo Ø, Nepstad I, Bruserud Ø, Reikvam H. Cytokines, adhesion molecules, and matrix metalloproteases as predisposing, diagnostic, and prognostic factors in venous thrombosis. Front Med. 2018;5: 147.
  Article Google Scholar
• Harjunpää H, Llort Asens M, Guenther C, Fagerholm SC. Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Front Immunol. 2019;10: 1078.
  Article PubMed PubMed Central Google Scholar
• Zhou Q, Liao JK. Pleiotropic effects of statins–basic research and clinical perspectives–. Circ J. 2010;74(5):818–26.
  Article CAS PubMed PubMed Central Google Scholar
• Dehnavi S, Kiani A, Sadeghi M, Biregani AF, Banach M, Atkin SL, et al. Targeting AMPK by statins: a potential therapeutic approach. Drugs. 2021;81(8):923–33.
• Koushki K, Shahbaz SK, Mashayekhi K, Sadeghi M, Zayeri ZD, Taba MY, et al. Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways. Clin Rev Allergy Immunol. 2021;60(2):175–99.
  Article CAS PubMed Google Scholar
• Bedi O, Dhawan V, Sharma P, Kumar P. Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(7):695–712.
  Article CAS PubMed Google Scholar
• Liao J, Duan Y, Liu Y, Chen H, An Z, Chen Y, et al. Simvastatin alleviates glymphatic system damage via the VEGF-C/VEGFR3/PI3K-Akt pathway after experimental intracerebral hemorrhage. Brain Res Bull. 2024;216: 111045.
  Article CAS PubMed Google Scholar
• Dehnavi S, Sohrabi N, Sadeghi M, Lansberg P, Banach M, Al-Rasadi K, et al. Statins and autoimmunity: state-of-the-art. Pharmacol Ther. 2020;214: 107614.
  Article CAS PubMed Google Scholar
• Kandelouei T, Abbasifard M, Imani D, Aslani S, Razi B, Fasihi M, et al. Effect of statins on serum level of hs-CRP and CRP in patients with cardiovascular diseases: a systematic review and meta-analysis of randomized controlled trials. Mediators Inflamm. 2022;2022:8732360.
  Article PubMed PubMed Central Google Scholar
• Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med. 2001;7(6):687–92.
  Article CAS PubMed Google Scholar
• Arefieva T, Filatova AY, Potekhina A, Shchinova A. Immunotropic effects and proposed mechanism of action for 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins). Biochem Mosc. 2018;83(8):874–89.
  Article CAS Google Scholar
• Murphy C, Deplazes E, Cranfield CG, Garcia A. The role of structure and biophysical properties in the pleiotropic effects of statins. Int J Mol Sci. 2020;21(22): 8745.
  Article CAS PubMed PubMed Central Google Scholar
• Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science. 2001;292(5519):1160–4.
  Article CAS PubMed Google Scholar
• Xie X, Tang Y. Efficient synthesis of simvastatin by use of whole-cell biocatalysis. Appl Environ Microbiol. 2007;73(7):2054–60.
  Article CAS PubMed PubMed Central Google Scholar
• Barrios-González J, Miranda RU. Biotechnological production and applications of statins. Appl Microbiol Biotechnol. 2010;85(4):869–83.
  Article PubMed Google Scholar
• Gazzerro P, Proto MC, Gangemi G, Malfitano AM, Ciaglia E, Pisanti S, et al. Pharmacological actions of statins: a critical appraisal in the management of cancer. Pharmacol Rev. 2012;64(1):102–46.
  Article CAS PubMed Google Scholar
• Shahbaz SK, Sadeghi M, Koushki K, Penson PE, Sahebkar A. Regulatory T cells: possible mediators for the anti-inflammatory action of statins. Pharmacol Res. 2019;149: 104469.
  Article CAS PubMed Google Scholar
• Mohammadkhani N, Gharbi S, Rajani HF, Farzaneh A, Mahjoob G, Hoseinsalari A, et al. Statins: complex outcomes but increasingly helpful treatment options for patients. Eur J Pharmacol. 2019;863: 172704.
  Article CAS PubMed Google Scholar
• Mollazadeh H, Tavana E, Fanni G, Bo S, Banach M, Pirro M, et al. Effects of statins on mitochondrial pathways. J Cachexia Sarcopenia Muscle. 2021;12(2):237–51.
  Article PubMed PubMed Central Google Scholar
• Sahebkar A, Serban C, Mikhailidis DP, Undas A, Lip GYH, Muntner P, et al. Association between statin use and plasma d-dimer levels: a systematic review and meta-analysis of randomised controlled trials. Thromb Haemost. 2015;114(3):546–57.
  PubMed Google Scholar
• Chruściel P, Sahebkar A, Rembek-Wieliczko M, Serban MC, Ursoniu S, Mikhailidis DP, et al. Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis. 2016;253:194–208.
  Article PubMed Google Scholar
• Sahebkar A, Foroutan Z, Katsiki N, Jamialahmadi T, Mantzoros CS. Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: is there a role for statin therapy? Metabolism: Clin Exp. 2023;146:146.
  Article Google Scholar
• Sahebkar A, Serban C, Ursoniu S, Mikhailidis DP, Undas A, Lip GYH, et al. The impact of statin therapy on plasma levels of von Willebrand factor antigen: systematic review and meta-analysis of randomised placebo-controlled trials. Thromb Haemost. 2016;115(3):520–32.
  Article PubMed Google Scholar
• Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109(23_suppl_1):III-39–III−43.
  Article Google Scholar
• Bland AR, Payne FM, Ashton JC, Jamialahmadi T, Sahebkar A. The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury. Pharmacol Res. 2022;175:105986.
• Sahebkar A, Chew GT, Watts GF. Recent advances in pharmacotherapy for hypertriglyceridemia. Prog Lipid Res. 2014;56(1):47–66.
  Article CAS PubMed Google Scholar
• Serban C, Sahebkar A, Ursoniu S, Mikhailidis DP, Rizzo M, Lip GYH, et al. A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Sci Rep. 2015;5:5.
  Article Google Scholar
• Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4(12):977–87.
  Article CAS PubMed Google Scholar
• Shishehbor MH, Brennan M-L, Aviles RJ, Fu X, Penn MS, Sprecher DL, et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation. 2003;108(4):426–31.
  Article CAS PubMed Google Scholar
• Bahrami A, Parsamanesh N, Atkin SL, Banach M, Sahebkar A. Effect of statins on toll-like receptors: a new insight to pleiotropic effects. Pharmacol Res. 2018;135:230–8.
  Article CAS PubMed Google Scholar
• Parizadeh SMR, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S, et al. Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. Lipids. 2011;46(4):333–40.
  Article CAS PubMed Google Scholar
• Schaafsma D, McNeill KD, Mutawe MM, Ghavami S, Unruh H, Jacques E, et al. Simvastatin inhibits TGFβ1-induced fibronectin in human airway fibroblasts. Respir Res. 2011;12(1):1–10.
  Article Google Scholar
• Vahedian-Azimi A, Mannarino MR, Shojaie S, Rahimibashar F, Galeh HEG, Banach M, et al. The effect of statins on prevalence and mortality of influenza virus infection: a systematic review and meta-analysis. Arch Med Sci. 2022;18(6).https://doi.org/10.5114/aoms/149633
• Vahedian-Azimi A, Mohammadi SM, Banach M, Beni FH, Guest PC, Al-Rasadi K, et al. Improved COVID-19 outcomes following statin therapy: an updated systematic review and meta-analysis. BioMed Res Int. 2021.https://doi.org/10.1155/2021/1901772
• Ling Q, Tejada-Simon M. Statins and the brain: new perspective for old drugs. Prog Neuropsychopharmacol Biol Psychiatry. 2016;66:80–6.
  Article CAS PubMed Google Scholar
• Kostapanos MS, Liberopoulos EN, Elisaf MS. Statin pleiotropy against renal injury. J Cardiometab Syndr. 2009;4(1):E4–9.
  Article PubMed Google Scholar
• Vahedian-Azimi A, Beni FH, Fras Z, Banach M, Mohammadi SM, Jamialahmadi T, et al. Effects of statins on the incidence and outcomes of acute kidney injury in critically ill patients: a systematic review and meta-analysis. Arch Med Sci. 2023;19(4):952–64.
  CAS PubMed PubMed Central Google Scholar
• Bhatta A. Comparison of CD28 and ICAM-1 signal transduction pathways, earliest signaling events involving CD45 and effect of statins and low pH on T cell function. University of Kansas; 2020. Available at: https://kuscholarworks.ku.edu/entities/publication/f464f04c-42af-4543-a7df-1a52021b0032.
• Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998;97(12):1129–35.
  Article CAS PubMed Google Scholar
• Laufs U, La Fata V, Liao JK. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem. 1997;272(50):31725–9.
  Article CAS PubMed Google Scholar
• Essig M, Nguyen G, Prié D, Escoubet B, Sraer J-D, Friedlander G. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells: role of geranylgeranylation and Rho proteins. Circ Res. 1998;83(7):683–90.
  Article CAS PubMed Google Scholar
• Hernández-Perera O, Pérez-Sala D, Navarro-Antolín J, Sánchez-Pascuala R, Hernández G, Díaz C, et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Investig. 1998;101(12):2711–9.
  Article PubMed PubMed Central Google Scholar
• Han L, Li M, Liu X. Effects of long-term atorvastatin treatment on cardiac aging. Exp Ther Med. 2013;6(3):721–6.
  Article CAS PubMed PubMed Central Google Scholar
• Parsamanesh N, Karami-Zarandi M, Banach M, Penson PE, Sahebkar A. Effects of statins on myocarditis: a review of underlying molecular mechanisms. Prog Cardiovasc Dis. 2021;67:53-64.
• Yudoh K, Karasawa R. Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis (OA). Aging (Albany NY). 2010;2(12):990.
  Article CAS PubMed Google Scholar
• Xie P, Dolivo DM, Jia S, Cheng X, Salcido J, Galiano RD, et al. Liposome-encapsulated statins reduce hypertrophic scarring through topical application. Wound Repair Regen. 2020;28(4):460–9.
  Article PubMed Google Scholar
• Gong X, Ma Y, Ruan Y, Fu G, Wu S. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta. Exp Gerontol. 2014;52:9–17.
  Article CAS PubMed Google Scholar
• Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, et al. HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells. J Clin Investig. 2001;108(3):399–405.
  Article CAS PubMed PubMed Central Google Scholar
• Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Investig. 2001;108(3):391–7.
  Article CAS PubMed PubMed Central Google Scholar
• Vaughan CJ, Gotto AM, Basson CT. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol. 2000;35(1):1–10.
  Article CAS PubMed Google Scholar
• Kouhpeikar H, Delbari Z, Sathyapalan T, Simental-Mendía LE, Jamialahmadi T, Sahebkar A. The effect of statins through mast cells in the pathophysiology of atherosclerosis: a review. Curr Atheroscler Rep. 2020;22:1–8.
  Article Google Scholar
• Peng D, Li Z. Effect of simvastatin on monocyte CX3CR1 expression in patients with acute coronary syndrome. J South Med Univ. 2008;28(3):475–7.
  CAS Google Scholar
• Kuznetsova G, Potekhina A, Aref’eva T, Ruleva NY, Filatova AY, Shchinova A, et al. Effect of atorvastatin on the blood T cell subset composition in patients with stable effort angina. Ateroskl Dislipidem. 2016;4:30–9.
• Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.
• Chang CH, Hsu YM, Chen YC, Lin FH, Sadhasivam S, Loo ST, et al. Anti-inflammatory effects of hydrophilic and lipophilic statins with hyaluronic acid against LPS-induced inflammation in porcine articular chondrocytes. J Orthop Res. 2014;32(4):557–65.
  Article CAS PubMed Google Scholar
• Yang SS, Li R, Qu X, Fang W, Quan Z. Atorvastatin decreases toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells. Cell Immunol. 2012;279(1):96–102.
  Article CAS PubMed Google Scholar
• Ferro D, Parrotto S, Basili S, Alessandri C, Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J Am Coll Cardiol. 2000;36(2):427–31.
  Article CAS PubMed Google Scholar
• Krysiak R, Okopien B. The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia. J Cardiovasc Pharmacol. 2011;57(4):505–12.
  Article CAS PubMed Google Scholar
• Veillard NR, Braunersreuther V, Arnaud C, Burger F, Pelli G, Steffens S, et al. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis. 2006;188(1):51–8.
  Article CAS PubMed Google Scholar
• Sahebkar A, Watts GF. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin Ther. 2013;35(8):1082–98.
  Article CAS PubMed Google Scholar
• Sahebkar A, Watts GF. New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect? Cardiovasc Drugs Ther. 2013;27(6):559–67.
  Article CAS PubMed Google Scholar
• Kim K, Ginsberg HN, Choi SH. New, novel lipid-lowering agents for reducing cardiovascular risk: beyond statins. Diabetes Metab J. 2022;46(4):517–32.
  Article PubMed PubMed Central Google Scholar
• Truong H, Danen EH. Integrin switching modulates adhesion dynamics and cell migration. Cell Adh Migr. 2009;3(2):179–81.
  Article PubMed PubMed Central Google Scholar
• Adu-Gyamfi EA, Czika A, Gorleku PN, Ullah A, Panhwar Z, Ruan L-L, et al. The involvement of cell adhesion molecules, tight junctions, and gap junctions in human placentation. Reprod Sci. 2020;28(2):305–20.
• Gahmberg CG, Grönholm M, Madhavan S, Jahan F, Mikkola E, Viazmina L, et al. Regulation of cell adhesion: a collaborative effort of integrins, their ligands, cytoplasmic actors, and phosphorylation. Q Rev Biophys. 2019;52:52.
  Article Google Scholar
• Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res. 2010;339(1):269–80.
  Article CAS PubMed Google Scholar
• Campbell ID, Humphries MJ. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol. 2011;3(3): a004994.
  Article PubMed PubMed Central Google Scholar
• Shimaoka M, Takagi J, Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct. 2002;31(1):485–516.
  Article CAS PubMed Google Scholar
• Fan Z, Ley K. Leukocyte arrest: biomechanics and molecular mechanisms of β2 integrin activation. Biorheology. 2015;52(5–6):353–77.
  CAS PubMed PubMed Central Google Scholar
• Hintermann E, Christen U. The many roles of cell adhesion molecules in hepatic fibrosis. Cells. 2019;8(12): 1503.
  Article CAS PubMed PubMed Central Google Scholar
• Kamal AHM, Chakrabarty JK, Udden SN, Zaki MH, Chowdhury SM. Inflammatory proteomic network analysis of statin-treated and lipopolysaccharide-activated macrophages. Sci Rep. 2018;8(1):1–13.
  Article Google Scholar
• Canalli AA, Proença RF, Franco-Penteado CF, Traina F, Sakamoto TM, Saad ST, et al. Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatin. Haematologica. 2011;96(4):526.
  Article CAS PubMed Google Scholar
• Zhang S, Rahman M, Zhang S, Qi Z, Thorlacius H. Simvastatin antagonizes CD40L secretion, CXC chemokine formation, and pulmonary infiltration of neutrophils in abdominal sepsis. J Leukoc Biol. 2011;89(5):735–42.
  Article CAS PubMed Google Scholar
• Silveira AAA, Dominical VM, Lazarini M, Costa FF, Conran N. Simvastatin abrogates inflamed neutrophil adhesive properties, in association with the inhibition of Mac-1 integrin expression and modulation of Rho kinase activity. Inflamm Res. 2013;62(2):127–32.
  Article CAS PubMed Google Scholar
• Silveira AAA, Dominical VM, Vital DM, Ferreira WA Jr, Costa FTM, Werneck CC, et al. Attenuation of TNF-induced neutrophil adhesion by simvastatin is associated with the inhibition of Rho-GTPase activity, p50 activity and morphological changes. Int Immunopharmacol. 2018;58:160–5.
  Article CAS Google Scholar
• Maher B, Dhonnchu TN, Burke J, Soo A, Wood A, Watson R. Statins alter neutrophil migration by modulating cellular Rho activity—a potential mechanism for statins-mediated pleotropic effects? J Leukoc Biol. 2009;85(1):186–93.
  Article CAS PubMed Google Scholar
• Cerda A, Rodrigues AC, Alves C, Genvigir FDV, Fajardo CM, Dorea EL, et al. Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients. Cardiovasc Ther. 2015;33(4):168–76.
  Article CAS PubMed Google Scholar
• Barbosa CP, Bracht L, Ames FQ, de Souza Silva-Comar FM, Tronco RP, Bersani-Amado CA. Effects of ezetimibe, simvastatin, and their combination on inflammatory parameters in a rat model of adjuvant-induced arthritis. Inflammation. 2017;40(2):717–24.
  Article CAS PubMed Google Scholar
• Hamblin MJ, Eberlein M, Black K, Hallowell R, Collins S, Chan-Li Y, et al. Lovastatin inhibits low molecular weight hyaluronan induced chemokine expression via LFA-1 and decreases bleomycin-induced pulmonary fibrosis. Int J Biomed Sci: IJBS. 2014;10(3):146.
  Article PubMed PubMed Central Google Scholar
• Korhonen M, Ylänne J, Laitinen L, Virtanen I. Distribution of beta 1 and beta 3 integrins in human fetal and adult kidney. Lab Investig; J Tech Methods pathol. 1990;62(5):616–25.
  CAS Google Scholar
• Adler S. Characterization of glomerular epithelial cell matrix receptors. Am J Pathol. 1992;141(3):571.
  CAS PubMed PubMed Central Google Scholar
• Liu J, Zhang B, Chai Y, Xu Y, Xing C, Wang X. Fluvastatin attenuated the effect of expression of β1 integrin in PAN-treated podocytes by inhibiting reactive oxygen species. Mol Cell Biochem. 2015;398(1):207–15.
  Article CAS PubMed Google Scholar
• Minami T, Satoh K, Nogi M, Kudo S, Miyata S, Tanaka S-i, et al. Statins up-regulate SmgGDS through β1-integrin/Akt1 pathway in endothelial cells. Cardiovasc Resarch. 2016;109(1):151–61.
  Article CAS Google Scholar
• Ge G, Hou Y. Statins protect diabetic myocardial microvascular endothelial cells from injury. International Journal of Diabetes in Developing Countries. 2018;38(4):424–36.
  Article CAS Google Scholar
• Li S, Cao C, Chen H, Song J, Lee C, Zhang J, et al. Atheroprotective effects of statins in patients with unstable angina by regulating the blood-borne microRNA network. Mol Med Rep. 2017;16(1):817–27.
  Article CAS PubMed PubMed Central Google Scholar
• deFilippi C, Toribio M, Wong LP, Sadreyev R, Grundberg I, Fitch KV, et al. Differential plasma protein regulation and statin effects in Human Immunodeficiency Virus (HIV)-infected and non-HIV-infected patients utilizing a proteomics approach. J Infect Dis. 2020;222(6):929–39.
  Article Google Scholar
• Alexander RW. Inflammation and coronary artery disease. N Engl J Med. 1994;331(7):468–9.
• Walter T, Suselbeck T, Borggrefe M, Swoboda S, Hoffmeister HM, Dempfle C-E. Effect of atorvastatin on cellular adhesion molecules on leukocytes in patients with normocholesterolemic coronary artery disease. In Vivo. 2010;24(2):189–93.
  CAS PubMed Google Scholar
• Johnson JL. Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis. Cardiovasc Res. 2014;103(4):452–60.
  Article CAS PubMed Google Scholar
• Chistiakov DA, Orekhov AN, Bobryshev YV. LOX-1-mediated effects on vascular cells in atherosclerosis. Cell Physiol Biochem. 2016;38(5):1851–9.
  Article CAS PubMed Google Scholar
• Sanyour HJ, Li N, Rickel AP, Torres HM, Anderson RH, Miles MR, et al. Statin-mediated cholesterol depletion exerts coordinated effects on the alterations in rat vascular smooth muscle cell biomechanics and migration. J Physiol. 2020;598(8):1505–22.
  Article CAS PubMed Google Scholar
• Nishida S, Matsuoka H, Tsubaki M, Tanimori Y, Yanae M, Fujii Y, et al. Mevastatin induces apoptosis in HL60 cells dependently on decrease in phosphorylated ERK. Mol Cell Biochem. 2005;269(1):109–14.
  Article CAS PubMed Google Scholar
• Kidera Y, Tsubaki M, Yamazoe Y, Shoji K, Nakamura H, Ogaki M, et al. Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway. J Exp Clin Cancer Res. 2010;29(1):1–11.
  Article Google Scholar
• Tsubaki M, Takeda T, Kino T, Obata N, Itoh T, Imano M, et al. Statins improve survival by inhibiting spontaneous metastasis and tumor growth in a mouse melanoma model. Am J Cancer Res. 2015;5(10):3186.
  CAS PubMed PubMed Central Google Scholar
• Relja B, Meder F, Wang M, Blaheta R, Henrich D, Marzi I, et al. Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK. Int J Oncol. 2011;38(3):879–85.
  Article CAS PubMed Google Scholar
• Morandi A, Taddei ML, Chiarugi P, Giannoni E. Targeting the metabolic reprogramming that controls epithelial-to-mesenchymal transition in aggressive tumors. Front Oncol. 2017;7:40.
  Article PubMed PubMed Central Google Scholar
• Nurwidya F, Takahashi F, Murakami A, Takahashi K. Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer. Cancer research and treatment: official journal of Korean Cancer Association. 2012;44(3):151.
  Article Google Scholar
• Jin H, He Y, Zhao P, Hu Y, Tao J, Chen J, et al. Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery. Theranostics. 2019;9(1):265.
  Article CAS PubMed PubMed Central Google Scholar
• Yang S-H, Lin H-Y, Changou CA, Chen C-H, Liu Y-R, Wang J, et al. Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma. Oncotarget. 2016;7(1):362.
  Article PubMed Google Scholar
• Delgado J, Nadeu F, Colomer D, Campo E. Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies. Haematologica. 2020;105(9):2205.
  Article CAS PubMed PubMed Central Google Scholar
• Burger JA, Gribben JG, editors. The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies. Seminars in cancer biology; 2014: Elsevier.
• Gimenez N, Tripathi R, Giró A, Rosich L, López-Guerra M, López-Oreja I, et al. Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia. Sci Rep. 2020;10(1):1–16.
  Article Google Scholar
• Tsubaki M, Takeda T, Obata N, Kawashima K, Tabata M, Imano M, et al. Combination therapy with dacarbazine and statins improved the survival rate in mice with metastatic melanoma. J Cell Physiol. 2019;234(10):17975–89.
  Article CAS PubMed Google Scholar
• Shao P-L, Wu S-C, Lin Z-Y, Ho M-L, Chen C-H, Wang C-Z. Alpha-5 integrin mediates simvastatin-induced osteogenesis of bone marrow mesenchymal stem cells. Int J Mol Sci. 2019;20(3): 506.
  Article CAS PubMed PubMed Central Google Scholar
• Kappelmayer J, Nagy B. The interaction of selectins and PSGL-1 as a key component in thrombus formation and cancer progression. BioMed Res Int. 2017;2017:6138145.
• Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996;88(9):3259-87.
• Krause T, Turner G. Are selectins involved in metastasis? Clin Exp Metas. 1999;17(3):183–92.
  Article CAS Google Scholar
• Schindler U, Baichwal VR. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol. 1994;14(9):5820–31.
  CAS PubMed PubMed Central Google Scholar
• Gnad R, Aktories K, Kaina B, Fritz G. Inhibition of protein isoprenylation impairs Rho-regulated early cellular response to genotoxic stress. Mol Pharmacol. 2000;58(6):1389–97.
  Article CAS PubMed Google Scholar
• Nübel T, Dippold W, Kleinert H, Kaina B, Fritz G. Lovastatin inhibits Rho-regulated expression of E-selectin by TNF-α and attenuates tumor cell adhesion. FASEB J. 2004;18(1):140–2.
  Article PubMed Google Scholar
• Lötsch F, Königsbrügge O, Posch F, Zielinski C, Pabinger I, Ay C. Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study. Thromb Res. 2014;134(5):1008–13.
  Article PubMed Google Scholar
• Janata K, Holzer M, Domanovits H, MüLLNER M, Bankier A, Kurtaran A, et al. Mortality of patients with pulmonary embolism. Wien Klin Wochenschr. 2002;114(17–18):766–72.
  PubMed Google Scholar
• Ashrani AA, Heit JA. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis. 2009;28(4):465–76.
  Article PubMed PubMed Central Google Scholar
• Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol. 2008;28(3):387–91.
  Article CAS PubMed Google Scholar
• Wakefield T, Strieter R, Prince M, Downing L, Greenfield L. Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg. 1997;5(1):6–15.
  Article CAS PubMed Google Scholar
• Feng Y, Lei B, Zhang F, Niu L, Zhang H, Zhang M. Anti-inflammatory effects of simvastatin during the resolution phase of experimentally formed venous thrombi. J Investig Med. 2017;65(6):999–1007.
  Article PubMed Google Scholar
• Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation. 2000;101(2):207–13.
  Article CAS PubMed Google Scholar
• Bickel C, Rupprecht HJ, Blankenberg S, Espinola-Klein C, Rippin G, Hafner G, et al. Influence of HMG–CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion. Int J Cardiol. 2002;82(1):25–31.
  Article PubMed Google Scholar
• Marschang P, Friedrich GJ, Ditlbacher H, Stoeger A, Zur Nedden D, Kirchmair R, et al. Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease. Int J Cardiol. 2006;106(2):183–90.
  Article PubMed Google Scholar
• Oka H, Ikeda S, Koga S, Miyahara Y, Kohno S. Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases. Heart Vessels. 2008;23(4):249–56.
  Article PubMed Google Scholar
• An K, Huang R, Tian S, Guo D, Wang J, Lin H, et al. Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis. Lipids Health Dis. 2019;18(1):1–11.
  Article CAS Google Scholar
• Kalawski R, Majewski M, Kaszkowiak E, Wysocki H, Siminiak T. Transcardiac release of soluble adhesion molecules during coronary artery bypass grafting: effects of crystalloid and blood cardioplegia. Chest. 2003;123(5):1355–60.
  Article CAS PubMed Google Scholar
• Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz M. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg. 2009;57(02):91–5.
  Article CAS PubMed Google Scholar
• Patti G, Chello M, Pasceri V, Colonna D, Nusca A, Miglionico M, et al. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. J Am Coll Cardiol. 2006;48(8):1560–6.
  Article CAS PubMed Google Scholar
• Patti G, Chello M, Gatto L, Alfano G, Miglionico M, Covino E, et al. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. Journal of Cardiovascular Medicine. 2010;11(11):795–800.
  Article PubMed Google Scholar
• Altun I, Oz F, Arkaya SC, Altun I, Bilge AK, Umman B, et al. Effect of statins on endothelial function in patients with acute coronary syndrome: a prospective study using adhesion molecules and flow-mediated dilatation. Journal of clinical medicine research. 2014;6(5):354.
  PubMed PubMed Central Google Scholar
• Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58(24):e44–122.
  Article PubMed Google Scholar
• Kling D, Stucki C, Kronenberg S, Tuerck D, Rhéaume E, Tardif J-C, et al. Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab–preclinical and clinical studies. Thromb Res. 2013;131(5):401–10.
  Article CAS PubMed Google Scholar
• Sexton TR, Wallace EL, Macaulay TE, Charnigo RJ, Evangelista V, Campbell CL, et al. The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome. J Thromb Thrombolysis. 2015;39(2):186–95.
  Article CAS PubMed Google Scholar
• Ren X, Akiyoshi K, Vandenbark AA, Hurn PD, Offner H. Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke. Stroke. 2011;42(9):2578–83.
  Article PubMed Google Scholar
• Miyazaki T, Kimura Y, Ohata H, Hashimoto T, Shibata K, Hasumi K, et al. Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion. Stroke. 2011;42(4):1097–104.
  Article CAS PubMed Google Scholar
• deVeber G. Arterial ischemic strokes in infants and children: an overview of current approaches. Semin Thromb Hemost. 2003;29(6):567–73.
• Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2003;53(2):167–73.
  Article Google Scholar
• Tu Q, Cao H, Zhong W, Ding B, Tang X. Atorvastatin protects against cerebral ischemia/reperfusion injury through anti-inflammatory and antioxidant effects. Neural Regen Res. 2014;9(3):268.
  Article CAS PubMed PubMed Central Google Scholar
• Aisiku IP, Smith WR, McClish DK, Levenson JL, Penberthy LT, Roseff SD, et al. Comparisons of high versus low emergency department utilizers in sickle cell disease. Ann Emerg Med. 2009;53(5):587–93.
  Article PubMed Google Scholar
• Owusu-Ansah A, Ihunnah CA, Walker AL, Ofori-Acquah SF. Inflammatory targets of therapy in sickle cell disease. Transl Res. 2016;167(1):281–97.
  Article CAS PubMed Google Scholar
• Hoppe C, Jacob E, Styles L, Kuypers F, Larkin S, Vichinsky E. Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial. Br J Haematol. 2017;177(4):620–9.
  Article CAS PubMed PubMed Central Google Scholar
• Wiewel MA, Scicluna BP, van Vught LA, Hoogendijk AJ, Zwinderman AH, Lutter R, et al. The host response in critically ill sepsis patients on statin therapy: a prospective observational study. Ann Intensive Care. 2018;8(1):1–12.
  Article CAS Google Scholar
• de Lorgeril M, Boissonnat P, Mamelle N, Martin J-L, Monjaud I, Guidollet J, et al. Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients. Circulation. 1994;89(6):2590–4.
  Article PubMed Google Scholar
• Aviram M, Hussein O, Rosenblat M, Schlezinger S, Hayek T, Keidar S. Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy. J Cardiovasc Pharmacol. 1998;31(1):39–45.
  Article CAS PubMed Google Scholar
• Andrews H, Aitken J, Hassall D, Skinner V, Bruckdorfer K. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. Biochemical Journal. 1987;242(2):559–64.
  Article CAS PubMed PubMed Central Google Scholar
• Labiós M, Martínez M, Gabriel F, Guiral V, Martínez E, Aznar J. Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cymetry. Thromb Res. 2005;115(4):263–70.
  Article PubMed Google Scholar
• Barale C, Frascaroli C, Senkeev R, Cavalot F, Russo I. Simvastatin effects on inflammation and platelet activation markers in hypercholesterolemia. Biomed Res Int. 2018;2018(1):6508709.
• Pawelczyk M, Chmielewski H, Kaczorowska B, Przybyła M, Baj Z. The influence of statin therapy on platelet activity markers in hyperlipidemic patients after ischemic stroke. Archives of medical science: AMS. 2015;11(1):115.
  Article PubMed PubMed Central Google Scholar
• Kotyla PJ. Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis. J Int Med Res. 2018;46(5):1893–901.
  Article CAS PubMed PubMed Central Google Scholar
• Sommeijer DW, Joop K, Leyte A, Reitsma P, Cate HT. Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes. J Thromb Haemost. 2005;3(6):1168–71.
  Article CAS PubMed Google Scholar
• Lee W-J, Lee W-L, Tang Y-J, Liang K-W, Chien Y-H, Tsou SS, et al. Early Improvements in insulin sensitivity and inflammatory markers are induced by pravastatin in nondiabetic subjects with hypercholesterolemia. Clin Chim Acta. 2008;390(1–2):49–55.
  Article CAS PubMed Google Scholar
• Mobarrez F, He S, Bröijersen A, Wiklund B, Antovic A, Antovic J, et al. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost. 2011;106(08):344–52.
  Article CAS PubMed Google Scholar
• Suades R, Padró T, Alonso R, Mata P, Badimon L. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. Thromb Haemost. 2013;110(08):366–77.
  Article CAS PubMed Google Scholar
• Wai Wong C, Dye DE, Coombe DR. The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol. 2012;2012(1):340296.
• Aricescu AR, Jones EY. Immunoglobulin superfamily cell adhesion molecules: zippers and signals. Curr Opin Cell Biol. 2007;19(5):543–50.
  Article CAS PubMed Google Scholar
• Cavallaro U, Dejana E. Adhesion molecule signalling: not always a sticky business. Nat Rev Mol Cell Biol. 2011;12(3):189–97.
  Article CAS PubMed Google Scholar
• Sakai M, Kobori S, Matsumura T, Biwa T, Sato Y, Takemura T, et al. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein. Atherosclerosis. 1997;133(1):51–9.
  Article CAS PubMed Google Scholar
• Manka DR, Wiegman P, Din S, Sanders JM, Green SA, Gimple LW, et al. Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of Apolipoprotein-E-deficient Mice1. J Vasc Res. 1999;36(5):372–8.
  Article CAS PubMed Google Scholar
• Seeger H, Wallwiener D, Mueck A. Lipid-independent effects of an estrogen–statin combination: inhibition of expression of adhesion molecules and plasminogen activator inhibitor-1 in human endothelial cell cultures. Climacteric. 2001;4(3):209–14.
  CAS PubMed Google Scholar
• Zapolska-Downar D, Siennicka A, Kaczmarczyk M, Kołodziej B, Naruszewicz M. Simvastatin modulates TNFα-induced adhesion molecules expression in human endothelial cells. Life Sci. 2004;75(11):1287–302.
  Article CAS PubMed Google Scholar
• Yoshida T, Yamashita M, Iwai M, Hayashi M. Endothelial Krüppel-like factor 4 mediates the protective effect of statins against ischemic AKI. J Am Soc Nephrol. 2016;27(5):1379–88.
  Article CAS PubMed Google Scholar
• Demir B, Onal B, Ozyazgan S, Demir E, Bakuy V, Akkan AG. The effects of pitavastatin on nuclear factor-kappa b and icam-1 in human saphenous vein graft endothelial culture. Cardiovasc Ther. 2019;2019(1):2549432.
• Böger RH, Bode-Böger SM, Frölich JC. The l-arginine—nitric oxide pathway: role in atherosclerosis and therapeutic implications. Atherosclerosis. 1996;127(1):1–11.
  Article PubMed Google Scholar
• Sardo MA, Castaldo M, Cinquegrani M, Bonaiuto M, Maesano A, Versace A, et al. Effects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjects. Clin Appl Thromb Hemost. 2002;8(3):257–63.
  Article CAS PubMed Google Scholar
• Xenos ES, Stevens SL, Freeman MB, Cassada DC, Goldman MH. Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells. Ann Vasc Surg. 2005;19(3):386–92.
  Article PubMed Google Scholar
• Dymkowska D, Wrzosek A, Zabłocki K. Atorvastatin and pravastatin stimulate nitric oxide and reactive oxygen species generation, affect mitochondrial network architecture and elevate nicotinamide N-methyltransferase level in endothelial cells. J Appl Toxicol. 2021;41(7):1076–88.
  Article CAS PubMed Google Scholar
• Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73(3):411–8.
  Article CAS PubMed Google Scholar
• Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol. 2009;196(2):193–222.
  Article CAS Google Scholar
• Garg N, Krishan P, Syngle A. Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis. Clin Rheumatol. 2015;34(6):1065–71.
  Article PubMed Google Scholar
• de Alwis N, Beard S, Mangwiro YT, Binder NK, Tu’uhevaha J, Brownfoot FC, et al. Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction. Pregnancy hypertension. 2020;20:83–91.
  Article PubMed Google Scholar
• Leisegang MS, Bibli S-I, Günther S, Pflüger-Müller B, Oo JA, Höper C, et al. Pleiotropic effects of laminar flow and statins depend on the Krüppel-like factor-induced lncRNA MANTIS. Eur Heart J. 2019;40(30):2523–33.
  Article CAS PubMed Google Scholar
• Imanparast F, Faramarzi MA, Vatannejad A, Paknejad M, Deiham B, Kobarfard F, et al. mZD7349 peptide-conjugated PLGA nanoparticles directed against VCAM-1 for targeted delivery of simvastatin to restore dysfunctional HUVECs. Microvasc Res. 2017;112:14–9.
  Article CAS PubMed Google Scholar
• Kwak BR, Mulhaupt F, Mach F. Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins. Autoimmun Rev. 2003;2(6):332–8.
  Article CAS PubMed Google Scholar
• Montecucco F, Burger F, Pelli G, Poku NK, Berlier C, Steffens S, et al. Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. Rheumatology. 2009;48(3):233–42.
  Article CAS PubMed Google Scholar
• Asai J, Takenaka H, Hirakawa S, Sakabe J-i, Hagura A, Kishimoto S, et al. Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. The American journal of pathology. 2012;181(6):2217–24.
  Article CAS PubMed Google Scholar
• Cakmak H, Basar M, Seval-Celik Y, Osteen KG, Duleba AJ, Taylor HS, et al. Statins inhibit monocyte chemotactic protein 1 expression in endometriosis. Reprod Sci. 2012;19(6):572–9.
  Article PubMed PubMed Central Google Scholar
• Hu Z, Zhang F, Yang Z, Yang N, Zhang D, Zhang J, et al. Combination of simvastatin administration and EPC transplantation enhances angiogenesis and protects against apoptosis for hindlimb ischemia. J Biomed Sci. 2008;15(4):509–17.
  Article CAS PubMed Google Scholar
• Urbich C, Dernbach E, Zeiher AM, Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res. 2002;90(6):737–44.
  Article CAS PubMed Google Scholar
• Dworacka M, Krzyżagórska E, Wesołowska A, Zharmakhanova G, Iskakova S, Dworacki G. Circulating monocyte chemotactic protein 1 (MCP-1), vascular cell adhesion molecule 1 (VCAM-1) and angiogenin in type 2 diabetic patients treated with statins in low doses. Eur J Pharmacol. 2014;740:474–9.
  Article CAS PubMed Google Scholar
• Guimarães ES, Cerda A, Dorea EL, Bernik MMS, Gusukuma MC, Pinto GA, et al. Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients. Cardiovasc Ther. 2017;35(6): e12307.
  Article Google Scholar
• Niedzielski M, Broncel M, Gorzelak-Pabiś P, Woźniak E. A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol. PLoS ONE. 2021;16(9): e0256996.
  Article CAS PubMed PubMed Central Google Scholar
• Sun C, Zheng W, Liang L, Liu Z, Sun W, Tang R. Ezetimibe improves rosuvastatin effects on inflammation and vascular endothelial function in acute coronary syndrome patients undergoing PCI. J Interv Cardiol. 2021;2021(1):2995602.
• Kim MH, Kim C-E, Kim S-W. Rosuvastatin inhibits high glucose-stimulated upregulation of VCAM-1 via the MAPK-signalling pathway in endothelial cells. Acta Cardiol. 2018;73(1):13–8.
  Article PubMed Google Scholar
• Park J, Hwang I, Kim S-J, Youn S-W, Hur J, Kim H-S. Atorvastatin prevents endothelial dysfunction in high glucose condition through Skp2-mediated degradation of FOXO1 and ICAM-1. Biochem Biophys Res Commun. 2018;495(2):2050–7.
  Article CAS PubMed Google Scholar
• Mason JE, Starke RD, Van Kirk JE. Gamma-Glutamyl transferase: a novel cardiovascular risk BioMarker. Prev Cardiol. 2010;13(1):36–41.
  Article CAS PubMed Google Scholar
• Lee D-H, Blomhoff R, Jacobs DR. Review is serum gamma glutamyltransferase a marker of oxidative stress? Free Radical Res. 2004;38(6):535–9.
  Article CAS Google Scholar
• Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, et al. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation. 2004;109(11):1440.
  Article PubMed Google Scholar
• Li G, Wu X-w, Lu W-h, Ai R, Chen F, Tang Z-z. Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E–knockout mice. BMC cardiovascular disorders. 2014;14(1):1–6.
  Article Google Scholar
• Pan X, Hou R, Ma A, Wang T, Wu M, Zhu X, et al. Atorvastatin upregulates the expression of miR-126 in apolipoprotein E-knockout mice with carotid atherosclerotic plaque. Cell Mol Neurobiol. 2017;37(1):29–36.
  Article CAS PubMed Google Scholar
• Clark MA, Duhay FG, Thompson AK, Keyes MJ, Svensson LG, Bonow RO, et al. Clinical and economic outcomes after surgical aortic valve replacement in Medicare patients. Risk management and healthcare policy. 2012;5:117.
  Article PubMed PubMed Central Google Scholar
• Venardos N, Deng X-S, Yao Q, Weyant MJ, Reece TB, Meng X, et al. Simvastatin reduces the TLR4-induced inflammatory response in human aortic valve interstitial cells. J Surg Res. 2018;230:101–9.
  Article CAS PubMed PubMed Central Google Scholar
• Altorki NK, Markowitz GJ, Gao D, Port JL, Saxena A, Stiles B, et al. The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer. 2019;19(1):9–31.
  Article CAS PubMed PubMed Central Google Scholar
• Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(23):5591–6.
  Article CAS PubMed Google Scholar
• Galland S, Martin P, Fregni G, Letovanec I, Stamenkovic I. Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins. Cancer Lett. 2020;484:50–64.
  Article CAS PubMed Google Scholar
• AL‐Husein B, Goc A, Somanath PR. Suppression of interactions between prostate tumor cell‐surface integrin and endothelial ICAM‐1 by simvastatin inhibits micrometastasis. J Cellular physiol. 2013;228(11):2139–48.
  Article Google Scholar
• Dzwonek J, Wilczynski GM. CD44: molecular interactions, signaling and functions in the nervous system. Front Cell Neurosci. 2015;9:175.
  Article PubMed PubMed Central Google Scholar
• Mishra MN, Chandavarkar V, Sharma R, Bhargava D. Structure, function and role of CD44 in neoplasia. Journal of Oral and Maxillofacial Pathology: JOMFP. 2019;23(2):267.
  Article PubMed PubMed Central Google Scholar
• Guo Q, Yang C, Gao F. The state of CD44 activation in cancer progression and therapeutic targeting. FEBS J. 2022;289(24):7970–86.
  Article CAS PubMed Google Scholar
• Beckwitt CH, Brufsky A, Oltvai ZN, Wells A. Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Res. 2018;20:1–11.
  Article Google Scholar
• Chimento A, Casaburi I, Avena P, Trotta F, De Luca A, Rago V, et al. Cholesterol and its metabolites in tumor growth: therapeutic potential of statins in cancer treatment. Front Endocrinol. 2019;9: 807.
  Article Google Scholar
• Mandal CC, Ghosh-Choudhury N, Yoneda T, Choudhury GG, Ghosh-Choudhury N. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44. J Biol Chem. 2011;286(13):11314–27.
  Article CAS PubMed PubMed Central Google Scholar
• Murai T, Maruyama Y, Mio K, Nishiyama H, Suga M, Sato C. Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J Biol Chem. 2011;286(3):1999–2007.
  Article CAS PubMed Google Scholar
• Rentala S, Chintala R, Guda M, Chintala M, Komarraju AL, Mangamoori LN. Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133+ CD44+ prostate cancer stem cells. Biochem Biophys Res Commun. 2013;441(3):586–92.
  Article CAS PubMed Google Scholar
• Koohestanimobarhan S, Salami S, Imeni V, Mohammadi Z, Bayat O. Lipophilic statins antagonistically alter the major epithelial-to-mesenchymal transition signaling pathways in breast cancer stem–like cells via inhibition of the mevalonate pathway. J Cell Biochem. 2019;120(2):2515–31.
  Article CAS PubMed Google Scholar
• Choi YS, Cho HJ, Jung HJ. Atorvastatin inhibits the proliferation of MKN45-derived gastric cancer stem cells in a mevalonate pathway-independent manner. The Korean Journal of Physiology & Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology. 2022;26(5):367–75.
  Article CAS Google Scholar
• Tanaka K, Osada H, Murakami-Tonami Y, Horio Y, Hida T, Sekido Y. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis. Cancer Lett. 2017;385:215–24.
  Article CAS PubMed Google Scholar
• Kato S, Liberona M, Cerda-Infante J, Sánchez M, Henríquez J, Bizama C, et al. Simvastatin interferes with cancer ‘stem-cell’plasticity reducing metastasis in ovarian cancer. Endocr Relat Cancer. 2018;25(10):821–36.
  Article CAS PubMed Google Scholar
• Aksoy S, Szumlanski CL, Weinshilboum RM. Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. Journal of Biological Chemistry. 1994;269(20):14835–40.
  Article CAS PubMed Google Scholar
• Wu Y, Siadaty M, Berens M, Hampton G, Theodorescu D. Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene. 2008;27(52):6679–89.
  Article CAS PubMed PubMed Central Google Scholar
• Bach D-H, Kim D, Bae SY, Kim WK, Hong J-Y, Lee H-J, et al. Targeting nicotinamide N-methyltransferase and miR-449a in EGFR-TKI-resistant non-small-cell lung cancer cells. Molecular Therapy-Nucleic Acids. 2018;11:455–67.
  Article CAS PubMed PubMed Central Google Scholar
• Yu T, Wang Y-T, Chen P, Li Y-H, Chen Y-X, Zeng H, et al. Effects of nicotinamide N-methyltransferase on PANC-1 cells proliferation, metastatic potential and survival under metabolic stress. Cell Physiol Biochem. 2015;35(2):710–21.
  Article CAS PubMed Google Scholar
• Lim B-H, Cho B-I, Kim YN, Kim JW, Park S-T, Lee C-W. Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp Mol Med. 2006;38(5):455–65.
  Article CAS PubMed Google Scholar
• Li J, You S, Zhang S, Hu Q, Wang F, Chi X, et al. Elevated N-methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform. Mol Oncol. 2019;13(9):1993–2009.
  Article CAS PubMed PubMed Central Google Scholar
• Abela GS, Katkoori VR, Pathak DR, Bumpers HL, Leja M, ul Abideen Z, et al. Cholesterol crystals induce mechanical trauma, inflammation, and neo-vascularization in solid cancers as in atherosclerosis. Am Heart J Plus Cardiol Res Pract, 2023;35:100317
• Mu D, Li J, Qi Y, Sun X, Liu Y, Shen S, et al. Novel hyaluronic acid-coated polymeric micelles with ROS scavenging to encapsulate statins for alleviating atherosclerosis. 2020. https://doi.org/10.21203/rs.3.rs-89851/v1.
• Nasr SH, Rashidijahanabad Z, Ramadan S, Kauffman N, Parameswaran N, Zinn KR, et al. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles. Nanoscale. 2020;12(17):9541–56.
  Article PubMed Central Google Scholar
• Rezaie-Majd A, Prager GW, Bucek RA, Schernthaner GH, Maca T, Kress H-G, et al. Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2003;23(3):397–403.
  Article CAS PubMed Google Scholar
• Dimitrova Y, Dunoyer-Geindre S, Reber G, Mach F, Kruithof E, De Moerloose P. Effects of statins on adhesion molecule expression in endothelial cells. J Thromb Haemost. 2003;1(11):2290–9.
  Article CAS PubMed Google Scholar
• Schmidmaier R, Baumann P, Simsek M, Dayyani F, Emmerich B, Meinhardt G. The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion–mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase. Blood. 2004;104(6):1825–32.
  Article CAS PubMed Google Scholar
• DeGorter MK, Tirona RG, Schwarz UI, Choi Y-H, Dresser GK, Suskin N, et al. Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care. Circulation: Cardiovascular Genetics. 2013;6(4):400–8.
  CAS PubMed Google Scholar